Table 3.
Correlations between monocyte counts and clinicopathological factors (categorical and ordinal variables).
| |
|
Monocyte counts |
≤0.4 × 109/L |
0.5–0.6 × 109/L |
≥0.7 × 109/L |
p value |
|---|---|---|---|---|---|---|
| No. | median (range) | n = 190 | n = 227 | n = 124 | ||
| Ethnicity | <0.001 | |||||
| Caucasian | 56 | 0.55 (0.3–0.9) | 10 (17.9%) | 30 (53.6%) | 16 (28.6%) | |
| African | 26 | 0.4 (0.1–1.8) | 17 (65.4%) | 3 (11.5%) | 6 (23.1%) | |
| Hispanic | 373 | 0.5 (0–1.6) | 122 (47.7%) | 160 (39.5%) | 91 (12.8%) | |
| Asian | 86 | 0.5 (0.1–1.0) | 41 (35.1%) | 34 (42.0%) | 11 (12.8%) | |
| Histology | 0.25 | |||||
| Endometrioid | 443 | 0.5 (0.1–1.6) | 157 (35.4%) | 187 (42.2%) | 99 (22.3%) | |
| Serous | 37 | 0.5 (0–1.8) | 15 (40.5%) | 15 (40.5%) | 7 (18.9%) | |
| Clear cell | 27 | 0.6 (0.3–1.2) | 8 (29.6%) | 8 (29.6%) | 11 (40.7%) | |
| Others | 34 | 0.5 (0.2–1.2) | 10 (29.4%) | 17 (50.0%) | 7 (20.6%) | |
| Grade | 0.51 | |||||
| 1 | 291 | 0.5 (0–1.3) | 103 (35.4%) | 125 (43.0%) | 63 (21.6%) | |
| 2 | 129 | 0.5 (0.1–1.6) | 48 (37.2%) | 53 (41.1%) | 28 (21.7%) | |
| 3 | 121 | 0.5 (0.1–1.8) | 39 (32.2%) | 49 (40.5%) | 33 (27.3%) | |
| Stage | 0.0003 | |||||
| I | 363 | 0.5 (0–1.8) | 143 (39.4%) | 153 (42.1%) | 67 (18.5%) | |
| II | 57 | 0.5 (0.3–1.4) | 18 (31.6%) | 25 (43.9%) | 14 (24.6%) | |
| III | 80 | 0.5 (0.2–1.5) | 17 (21.3%) | 37 (29.3%) | 26 (32.5%) | |
| IV | 41 | 0.6 (0.1–1.3) | 12 (29.3%) | 12 (29.3%) | 17 (41.5%) | |
| LVSI | 0.19 | |||||
| Absence | 438 | 0.5 (0–1.8) | 158 (36.1%) | 186 (42.5%) | 94 (21.5%) | |
| Presence | 97 | 0.5 (0.1–1.1) | 30 (30.9%) | 40 (41.2%) | 27 (27.8%) | |
| Myometrial invasion | 0.005 | |||||
| ≤50% | 403 | 0.5 (0–1.8) | 154 (38.2%) | 166 (41.2%) | 83 (20.6%) | |
| >50% | 127 | 0.5 (0.1–1.4) | 31 (24.4%) | 59 (46.5%) | 37 (29.1%) | |
| Pelvic lymph nodes | 0.039 | |||||
| No metastasis | 223 | 0.5 (0.1–1.3) | 86 (38.6%) | 95 (42.6%) | 42 (18.8%) | |
| Metastasis | 41 | 0.6 (0.3–1.2) | 11 (26.8%) | 14 (34.1%) | 16 (39.0%) |
Mann-Whitney U test or Kruskal-Wallis test for p values. Significant p values are in bold. Abbreviation: LVSI, lymphovascular space invasion.